-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOMMUNE - PHASE 1 TRIAL FOR EVO570 EXPECTED TO BEGIN IMMINENTLY; PHASE 2 IN RHEUMATOID ARTHRITIS PLANNED FOR 2027

Reuters·11/04/2026 22:02:00

Please log in to view news